The Fort Worth Press - Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform

USD -
AED 3.6731
AFN 64.000125
ALL 83.310487
AMD 377.390171
ANG 1.790083
AOA 917.000032
ARS 1394.6999
AUD 1.411961
AWG 1.8
AZN 1.698169
BAM 1.696352
BBD 2.017025
BDT 122.885307
BGN 1.709309
BHD 0.377557
BIF 2970
BMD 1
BND 1.278723
BOB 6.920298
BRL 5.205304
BSD 1.001487
BTN 92.872847
BWP 13.580798
BYN 3.052406
BYR 19600
BZD 2.014155
CAD 1.370005
CDF 2269.999753
CHF 0.78972
CLF 0.02318
CLP 915.279629
CNY 6.87305
CNH 6.88653
COP 3706.7
CRC 467.742425
CUC 1
CUP 26.5
CVE 97.049978
CZK 21.225097
DJF 177.7205
DKK 6.4883
DOP 60.050274
DZD 132.416153
EGP 52.253496
ERN 15
ETB 156.999833
EUR 0.86831
FJD 2.21245
FKP 0.749449
GBP 0.74957
GEL 2.714976
GGP 0.749449
GHS 10.905026
GIP 0.749449
GMD 73.999838
GNF 8779.99989
GTQ 7.671558
GYD 209.520258
HKD 7.83815
HNL 26.569497
HRK 6.543203
HTG 131.24607
HUF 340.140278
IDR 16961
ILS 3.10005
IMP 0.749449
INR 92.88435
IQD 1310
IRR 1315000.000238
ISK 124.370104
JEP 0.749449
JMD 157.249479
JOD 0.708995
JPY 159.335997
KES 129.549986
KGS 87.449829
KHR 4009.999882
KMF 427.999727
KPW 899.9784
KRW 1501.410171
KWD 0.30644
KYD 0.834501
KZT 483.111229
LAK 21449.999713
LBP 89550.000042
LKR 311.844884
LRD 183.349753
LSL 16.820103
LTL 2.95274
LVL 0.60489
LYD 6.380061
MAD 9.37375
MDL 17.460159
MGA 4169.999712
MKD 53.541262
MMK 2100.10344
MNT 3571.101739
MOP 8.084959
MRU 40.11989
MUR 46.510272
MVR 15.459872
MWK 1736.000271
MXN 17.707895
MYR 3.915496
MZN 63.900902
NAD 16.819834
NGN 1356.939807
NIO 36.720274
NOK 9.56654
NPR 148.591748
NZD 1.71111
OMR 0.384495
PAB 1.001483
PEN 3.427502
PGK 4.30275
PHP 59.782501
PKR 279.290359
PLN 3.70598
PYG 6472.539624
QAR 3.644007
RON 4.421402
RSD 101.991987
RUB 83.889591
RWF 1459
SAR 3.754945
SBD 8.04524
SCR 14.089128
SDG 600.999851
SEK 9.332675
SGD 1.279575
SHP 0.750259
SLE 24.650411
SLL 20969.510825
SOS 571.499098
SRD 37.374981
STD 20697.981008
STN 21.5
SVC 8.762663
SYP 110.58576
SZL 16.820092
THB 32.617011
TJS 9.578717
TMT 3.5
TND 2.917506
TOP 2.40776
TRY 44.202397
TTD 6.788466
TWD 31.932498
TZS 2603.729567
UAH 44.042968
UGX 3767.67725
UYU 40.557008
UZS 12175.000113
VES 450.942841
VND 26310
VUV 119.592862
WST 2.733704
XAF 568.900934
XAG 0.013003
XAU 0.000205
XCD 2.70255
XCG 1.80488
XDR 0.70688
XOF 566.5008
XPF 103.914716
YER 238.575025
ZAR 16.80645
ZMK 9001.203552
ZMW 19.583865
ZWL 321.999592
  • RBGPF

    0.1000

    82.5

    +0.12%

  • RYCEF

    -0.0800

    16.7

    -0.48%

  • CMSC

    -0.1000

    22.85

    -0.44%

  • NGG

    -2.4450

    87.975

    -2.78%

  • BTI

    -2.1300

    58.42

    -3.65%

  • RIO

    -1.3800

    88.42

    -1.56%

  • RELX

    -0.1050

    34.185

    -0.31%

  • GSK

    -1.0300

    52.38

    -1.97%

  • BCE

    -0.2150

    25.795

    -0.83%

  • AZN

    -1.5300

    189.76

    -0.81%

  • CMSD

    -0.0800

    22.8

    -0.35%

  • BCC

    -0.2550

    72.665

    -0.35%

  • BP

    0.5900

    44.44

    +1.33%

  • JRI

    -0.0800

    12.38

    -0.65%

  • VOD

    -0.2600

    14.49

    -1.79%

Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into  AI-Powered Preventative Screening Platform
Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform

Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform

LAS VEGAS, NEVADA / ACCESS Newswire / May 27, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are exploring options to integrate the early detection of dementia into Ainnova's proprietary, AI-powered platform technology, Vision AI. The addition would reinforce the Company's mission of expanding AI-powered early detection and preventative health solutions across the globe.

Text size:

Currently, the Company has identified a promising patented early disease detection technology specializing in the early detection of dementia and is exploring its options to either license the technology globally or potentially acquire the technology altogether. The patented technology combines AI algorithms and hardware based on a 5-minute blood test. Adding the early detection of dementia would expand the offerings in the Company's technology portfolio and enhance the broader vision of the partnership between Avant and Ainnova.

The success of the Company's preventative screening platform involves the deployment of an automated, low-cost retinal imaging device integrated with the Vision AI platform to deliver comprehensive preventive risk screening. Presently, from just two retinal images, blood pressure and some lab test information, the Company's system uses 4 integrated algorithms to assess risks for: (i) cardiovascular disease (CVD), (ii) type 2 diabetes, (iii) liver fibrosis, and (iv) chronic kidney disease (CKD).

Vinicio Vargas, Chief Executive Officer at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp., said of the potential expansion of its technology portfolio, "This accessible, fast, and scalable solution is designed to support early intervention and targeted treatment strategies, with the ambition of reaching millions of patients globally in the coming years. Adding the early detection of dementia that this patented technology presents us, would go a long way to making us a leader in the industry of early disease detection."

About Ainnova Tech, Inc.

Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.

About Avant Technologies Inc.

Avant Technologies Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI
https://www.linkedin.com/company/avant-technologies-ai
https://www.facebook.com/AvantTechAI
https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.

Contact:

Avant Technologies Inc.
[email protected]

SOURCE: Avant Technologies Inc.



View the original press release on ACCESS Newswire

H.Carroll--TFWP